US-based medical device company Respiratory Motion has secured the CE Mark for ExSpiron to facilitate a faster detection of life threatening respiratory depression.
ExSpiron is a respiratory volume monitoring system which issues an early warning triggered by a fluctuation in respiratory status which is considered 15-30 minutes faster than the conventional measures.
Respiratory Motion CEO Jenny Freeman said: "Clinicians around the world rely on minute ventilation (MV) to make decisions on the respiratory status of patients on mechanical ventilators."
The system includes a range of features such asa clear, intuitive touch screen graphical user interface (GUI) which clearly displays real-time waveforms, trends and numeric data.
It is based on the disposable Patient PadSet technology, which makes the device easy to use for patients.
ExSpiron allows saving and printing of reports and can be connected with a USB.
The device includes other features including a patient cable; a self-contained battery which runs for more than two hours; an IV pole mount; electronic health record (EHR) integration options; nurse call interface and a Philips VueLink / IntelliBridge.
Metropolitan Anesthesia Consultants co-founder Tillmann Hein said: "By showing each breath that is taken on a Minute Ventilation monitor, clinicians can immediately assess a patient's work of breathing, and identify at-risk patients and provide early detection of low minute ventilation.
"This can enable my staff to adjust opioid dosing and ensure optimal pain management."
Image: An image of ExSpiron minute ventilation monitor. Photo: courtesy of PR Newswire Association LLC.